Sodium intake is associated with increased disease activity in multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 1, 2015, Pages 26-31

  Farez, Mauricio F ^a   Fiol, Marcela P ^a   Gaitán, María I ^a   Quintana, Francisco J ^b   Correale, Jorge ^a  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; SODIUM; VITAMIN D;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; REGRESSION ANALYSIS; SODIUM BLOOD LEVEL; SODIUM INTAKE; SODIUM URINE LEVEL; BLOOD; BRAIN; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROIMAGING; PATHOLOGY; RECURRENT DISEASE; URINE; YOUNG ADULT;

ADULT; BRAIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROIMAGING; RECURRENCE; SODIUM; VITAMIN D; YOUNG ADULT;

EID: 84919780325     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307928     Document Type: Article

References (34)

1. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008;7:268-77.
2. Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13:1173-5.
3. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009;132:1146-60.
4. Ascherio A, Munger KL, Lennette ET, et al . Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286:3083-8.
5. Correale J, Fiol M, Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006;67:652-9.
6. Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007;61:97-108.
7. Farez MF, Correale J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol 2011;258:1197-206.
8. Wu C, Yosef N, Thalhamer T, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013;496:513-17.
9. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013;496:518-22.
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
11. Holbrook JT, Patterson KY, Bodner JE, et al. Sodium and potassium intake and balance in adults consuming self-selected diets. Am J Clin Nutr 1984;40:786-93.
12. Mann SJ, Gerber LM. Estimation of 24-hour sodium excretion from spot urine samples. J Clin Hypertens (Greenwich) 2010;12:174-80.
13. Tanaka T, Okamura T, Miura K, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens 2002;16:97-103.
14. Kawano Y, Tsuchihashi T, Matsuura H, et al. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (2) Assessment of salt intake in the management of hypertension. 2007;887-93.
15. Legetic B, Campbell N. Reducing salt intake in the Americas: Pan American Health Organization Actions. J Health Commun 2011;16:37-48.
16. Loken-Amsrud KI, Holmoy T, Bakke SJ, et al. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment. Neurology 2012;79:267-73.
17. Appel LJ, Baker D, Bar-Or O, et al. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. National Academies Press, 2005.
18. Liamis G, Elisaf M. Syndrome of inappropriate antidiuresis associated with multiple sclerosis. J Neurol Sci 2000;172:38-40.
19. Woodruff SJ, Fryer K, Campbell T, et al. Associations among blood pressure, salt consumption and body weight status of students from south-western Ontario. Public Health Nutr 2014;17:1114-19
20. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology 2009;73:1543-50.
21. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10.
22. Thierry-Palmer M, Tewolde TK, Forté C, et al. Plasma 24,25-dihydroxyvitamin D concentration of Dahl salt-sensitive rats decreases during high salt intake. J Steroid Biochem Mol Biol 2002;80:315-21.
23. De Miguel C, Das S, Lund H, et al. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2010;298:R1136-42.
24. He FJ, Marciniak M, Visagie E, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009;54:482-8.
25. Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. JExp Med 2007;204:2449-60.
26. Madhur MS, Lob HE, McCann LA, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010;55:500-7.
27. Knox AJ. Salt and asthma. BMJ 1993;307:1159-60.
28. Pogson Z, McKeever T. Dietary sodium manipulation and asthma. Cochrane Database Syst Rev 2011;16(3):CD000436.
29. Thomas MC, Moran J, Forsblom C, et al. The Association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011;34:861-6.
30. Brucklacher-Waldert V, Stuerner K, Kolster M, et al. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009;132:3329-41.
31. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8.
32. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-54.
33. Stegbauer J, Lee D-H, Seubert S, et al. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA 2009;106:14942-7.
34. Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 2012;11:1039-47.